Britannica Sources used in this answer

How could embryonic stem cells provide dopamine-producing neurons for Parkinson disease research?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Diagram showing the locations of neural stem cells in brain regions such as the hippocampus and ventricles, and hematopoietic stem cells in the bone marrow and blood, with labeled illustrations of the brain, spinal cord, circulatory system, and skeleton. — stem cell Stem cells of neural and hematopoietic origin have tremendous potential in the development of therapies for certain diseases, such as diabetes and Parkinson disease. Neural stem cells occur in the spinal cord and in specific regions of the brain, and hematopoietic stem cells occur in the blood and bone marrow.

Embryonic stem cells (ESCs) offer a promising avenue for Parkinson disease research because they are pluripotent, meaning they possess the capacity to differentiate into any cell type in the human body, including the dopaminergic neurons that are lost or damaged in patients with the condition.12

Researchers can influence ESCs to develop into these specific dopamine-producing neurons in a laboratory setting. This process is particularly valuable because alternative sources, such as fetal mesencephalic tissue, are in extremely limited supply. By generating large banks of pure, certified dopaminergic precursor cells from ESCs, scientists aim to create a reliable source of healthy cells for transplantation into the striata of patients.12

However, significant challenges remain in this field. These include:
* Differentiation Time: Human ESCs require a longer period to differentiate compared to mouse ESCs.1
* Safety and Purity: Techniques must ensure that transplanted cell populations are pure and free of non-dopaminergic cells.1
* Survival and Integration: Researchers must develop methods to ensure the transplanted cells survive for prolonged periods and integrate properly into existing neuronal networks.1